Pacer Advisors, Inc. Johnson & Johnson Transaction History

Pacer Advisors, Inc.

$41.8 Billion
Q3 2024

A detailed history of Pacer Advisors, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Pacer Advisors, Inc. holds 265,688 shares of JNJ stock, worth $41.1 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

265,688

Previous 240,605 10.42%

Holding current value

$41.1 Million

Previous $35.2 Million 22.44%

% of portfolio

0.1%

Previous 0.09%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$145.48 - $167.38 $3.65 Million - $4.2 Million	25,083 Added 10.42%	265,688 $43.1 Million
Q2 2024 Aug 13, 2024	BUY	$144.38 - $157.78 $4.61 Million - $5.03 Million	31,908 Added 15.29%	240,605 $35.2 Million
Q1 2024 May 10, 2024	BUY	$155.22 - $162.74 $3.89 Million - $4.07 Million	25,034 Added 13.63%	208,697 $33 Million
Q4 2023 Jan 16, 2024	BUY	$145.6 - $158.88 $3.85 Million - $4.2 Million	26,461 Added 16.83%	183,663 $28.8 Million
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $1.24 Million - $1.39 Million	-7,990 Reduced 4.84%	157,202 $24.5 Million
Q2 2023 Jul 12, 2023	BUY	$154.35 - $166.11 $600,575 - $646,334	3,891 Added 2.41%	165,192 $27.3 Million
Q1 2023 May 02, 2023	BUY	$151.05 - $180.26 $10.5 Million - $12.6 Million	69,842 Added 76.36%	161,301 $25 Million
Q4 2022 Feb 06, 2023	BUY	$160.2 - $179.79 $13 Million - $14.6 Million	81,343 Added 804.1%	91,459 $16.2 Million
Q3 2022 Oct 18, 2022	SELL	$161.33 - $179.52 $9.1 Million - $10.1 Million	-56,430 Reduced 84.8%	10,116 $1.65 Million
Q2 2022 Aug 12, 2022	SELL	$168.19 - $186.01 $11.9 Million - $13.2 Million	-70,833 Reduced 51.56%	66,546 $11.8 Million
Q1 2022 Apr 05, 2022	SELL	$158.14 - $179.59 $351,861 - $399,587	-2,225 Reduced 1.59%	137,379 $24.3 Million
Q4 2021 Feb 03, 2022	SELL	$155.93 - $173.01 $3.2 Million - $3.56 Million	-20,551 Reduced 12.83%	139,604 $23.9 Million
Q3 2021 Oct 15, 2021	BUY	$161.5 - $179.47 $1.51 Million - $1.68 Million	9,365 Added 6.21%	160,155 $25.9 Million
Q2 2021 Jul 21, 2021	BUY	$159.48 - $171.07 $769,969 - $825,925	4,828 Added 3.31%	150,790 $24.8 Million
Q1 2021 Apr 05, 2021	SELL	$153.07 - $170.48 $1.97 Million - $2.19 Million	-12,863 Reduced 8.1%	145,962 $24 Million
Q4 2020 Jan 20, 2021	SELL	$137.11 - $157.38 $4.64 Million - $5.33 Million	-33,871 Reduced 17.58%	158,825 $25 Million
Q3 2020 Oct 19, 2020	SELL	$140.38 - $153.83 $4.53 Million - $4.96 Million	-32,251 Reduced 14.34%	192,696 $28.7 Million
Q2 2020 Jul 29, 2020	BUY	$128.81 - $155.51 $29 Million - $35 Million	224,947 New	224,947 $31.6 Million
Q1 2020 Apr 23, 2020	SELL	$111.14 - $153.99 $33.5 Million - $46.4 Million	-301,184 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$127.5 - $146.44 $2 Million - $2.3 Million	15,698 Added 5.5%	301,184 $43.9 Million
Q3 2019 Oct 10, 2019	BUY	$126.95 - $142.14 $3.86 Million - $4.32 Million	30,395 Added 11.92%	285,486 $36.9 Million
Q2 2019 Aug 12, 2019	BUY	$131.15 - $144.24 $2.05 Million - $2.25 Million	15,612 Added 6.52%	255,091 $35.5 Million
Q1 2019 Apr 10, 2019	BUY	$125.72 - $139.79 $30.1 Million - $33.5 Million	239,316 Added 146819.62%	239,479 $33.5 Million
Q4 2018 Feb 13, 2019	SELL	$122.84 - $147.84 $17.6 Million - $21.2 Million	-143,197 Reduced 99.89%	163 $21,000
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $2.16 Million - $2.53 Million	17,736 Added 14.12%	143,360 $19.8 Million
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $2.77 Million - $3.05 Million	23,172 Added 22.62%	125,624 $15.2 Million
Q1 2018 May 14, 2018	BUY	$125.1 - $148.14 $1.44 Million - $1.7 Million	11,499 Added 12.64%	102,452 $13.1 Million
Q4 2017 Feb 14, 2018	BUY	$131.22 - $143.62 $2.64 Million - $2.89 Million	20,106 Added 28.38%	90,953 $12.7 Million
Q3 2017 Nov 08, 2017	BUY	$129.47 - $135.38 $9.17 Million - $9.59 Million	70,847	70,847 $9.21 Million

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $404B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account

Pacer Advisors, Inc. Johnson & Johnson Transaction History